0001579587-24-000013.txt : 20240611
0001579587-24-000013.hdr.sgml : 20240611
20240611165143
ACCESSION NUMBER: 0001579587-24-000013
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240607
FILED AS OF DATE: 20240611
DATE AS OF CHANGE: 20240611
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Marken James G.
CENTRAL INDEX KEY: 0001579587
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31812
FILM NUMBER: 241036452
MAIL ADDRESS:
STREET 1: 210 MAIN STREET WEST
STREET 2: C/O BIOSANTE PHARMACEUTICALS, INC.
CITY: BAUDETTE
STATE: MN
ZIP: 56623
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ANI PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001023024
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 582301143
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 210 MAIN STREET WEST
CITY: BAUDETTE
STATE: MN
ZIP: 56623
BUSINESS PHONE: 2186343500
MAIL ADDRESS:
STREET 1: 210 MAIN STREET WEST
CITY: BAUDETTE
STATE: MN
ZIP: 56623
FORMER COMPANY:
FORMER CONFORMED NAME: BIOSANTE PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19991228
FORMER COMPANY:
FORMER CONFORMED NAME: BEN ABRAHAM TECHNOLOGIES INC
DATE OF NAME CHANGE: 19991027
4
1
wk-form4_1718139096.xml
FORM 4
X0508
4
2024-06-07
0
0001023024
ANI PHARMACEUTICALS INC
ANIP
0001579587
Marken James G.
C/O ANI PHARMACEUTICALS, INC.
210 MAIN STREET WEST
BAUDETTE
MN
56623
0
1
0
0
SVP OPS & PROD DEV
0
Common Stock
2024-06-07
4
M
0
7250
49.51
A
123616
D
Common Stock
2024-06-07
4
M
0
5300
57.06
A
128916
D
Common Stock
2024-06-07
4
F
0
11087
67.70
D
117829
D
Stock Option (right to buy)
49.51
2024-06-07
4
M
0
7250
49.51
D
2027-03-30
Common Stock
7250
0
D
Stock Option (right to buy)
57.06
2024-06-07
4
M
0
5300
57.06
D
2028-04-05
Common Stock
5300
0
D
The number of shares beneficially owned by the reporting person is amended in this Form 4 to correct an administrative error in a Form 4 filed on March 9, 2023, which misreported that 1,951 shares were withheld on March 7, 2023 to cover taxes on a vesting of shares on that date, when 1,591 shares were withheld. In correcting this administrative error, the number of shares beneficially owned by the reporting person reflects an increase of 360 shares.
The shares were sold in multiple trades at prices ranging from $67.64 to $68.10. The price reported above reflects the weighted average sales price.
25% of the total options vested on each of March 31, 2018, March 31, 2019, March 31, 2020, and March 31, 2021.
25% of the total options vested on each of April 6, 2019, April 6, 2020, April 6, 2021, and April 6, 2022.
/s/ James G. Marken, by attorney-in-fact Meredith W. Cook
2024-06-11